Your browser doesn't support javascript.
loading
Standardization of lower extremity quantitative lymphedema measurements and associated patient-reported outcomes in gynecologic cancers.
Russo, Sandra; Walker, Joan L; Carlson, Jay W; Carter, Jeanne; Ward, Leigh C; Covens, Allan; Tanner, Edward J; Armer, Jane M; Ridner, Sheila; Hayes, Sandi; Taghian, Alphonse G; Brunelle, Cheryl; Lopez-Acevedo, Micael; Davidson, Brittany A; Schaverien, Mark V; Ghamande, Sharad A; Bernas, Michael; Cheville, Andrea L; Yost, Kathleen J; Schmitz, Kathryn; Coyle, Barbara; Zucker, Jeannette; Enserro, Danielle; Pugh, Stephanie; Paskett, Electra D; Ford, Leslie; McCaskill-Stevens, Worta.
Affiliation
  • Russo S; National Cancer Institute, Division of Cancer Prevention, 9609 Medical Center Drive, Rockville, MD 20892-9785, USA. Electronic address: sandra.russo@nih.gov.
  • Walker JL; Stephen Cancer Center, OUHSC, Oklahoma City, OK 73104, USA. Electronic address: joan-walker@ouhsc.edu.
  • Carlson JW; Cancer Research for Ozarks, 1235 E. Cherokee, Springfield, MO 65804, USA. Electronic address: jay.carlson@mercy.net.
  • Carter J; Memorial Sloan Kettering Cancer Center, 641 Lexington Avenue, New York, NY, 10022, USA. Electronic address: carterj@mskcc.org.
  • Ward LC; University of Queensland, St Lucia, Brisbane, QLD 4072, Australia. Electronic address: l.ward@uq.edu.au.
  • Covens A; University of Toronto and Sunnybrook Health Science Centre, Toronto, ON M4N 3M5, Canada. Electronic address: al.covens@sunnybrook.ca.
  • Tanner EJ; Northwestern Medicine, Feinberg School of Medicine, Prentice Women's Hospital, 250 E Superior, Chicago, IL 60611, USA. Electronic address: edward.tanner@nm.org.
  • Armer JM; Sinclair School of Nursing, University of Missouri Health, DC 116.05, Ellis Fischel Cancer Center, 115 Business Loop 70 West, Columbia, MO 65203, USA. Electronic address: armer@missouri.edu.
  • Ridner S; Vanderbilt University School of Nursing, 461 21st Ave South, Nashville, TN 37240, USA. Electronic address: sheila.ridner@vanderbilt.edu.
  • Hayes S; Queensland University of Technology, School of Public Health and Biomedical Innovation, Queensland, Australia. Electronic address: sc.hayes@qut.edu.au.
  • Taghian AG; Harvard Medical School/Massachusetts General Hospital, Radiation Oncology, Boston, MA 02114, USA. Electronic address: ataghian@mgh.harvard.edu.
  • Brunelle C; Massachusetts General Hospital Cancer Center, 55 Fruit Street, Boston, MA 02114, USA. Electronic address: cbrunelle@mgh.harvard.edu.
  • Lopez-Acevedo M; The George Washington University Hospital, School of Medicine and Health Sciences, 2150 Pennsylvania Ave, NW, Washington, DC 20037, USA. Electronic address: mlopezacevedo@mfa.gwu.edu.
  • Davidson BA; Duke University School of Medicine, Duke Cancer Center, 20 Duke Medical Center, Durham, NC 27710, USA. Electronic address: brittany.davidson@duke.edu.
  • Schaverien MV; The University of Texas M.D. Anderson Cancer Center, Houston, TX 77030, USA. Electronic address: mvschaverien@mdanderson.org.
  • Ghamande SA; Augusta University, Augusta Oncology, 3696 Wheeler Road, Augusta, GA 30909, USA. Electronic address: sghamande@augusta.edu.
  • Bernas M; TCU and UNTHSC School of Medicine, Forth Worth, TX 76207, USA. Electronic address: mbernas@tcu.edu.
  • Cheville AL; Mayo Clinic, 200 First St SW, Rochester, MN 55905, USA. Electronic address: cheville.andrea@mayo.edu.
  • Yost KJ; Mayo Clinic, 200 First St SW, Rochester, MN 55905, USA. Electronic address: yost.kathleen@mayo.edu.
  • Schmitz K; Penn State Cancer Institute, 400 University Drive, Hershey, PA 17033, USA. Electronic address: kzs95@psu.edu.
  • Coyle B; Patient Advocate, Lymphedema Advocacy Group, Minneapolis, MN, USA.
  • Zucker J; National Lymphedema Network, 411 Lafayette Street, 6th Floor, New York, NY 10003, USA. Electronic address: jeannette.zucker@lymphnet.org.
  • Enserro D; NRG Oncology Statistics and Data Management Center, Roswell Park Comprehensive Cancer Center, Buffalo, NY 14263, USA. Electronic address: enserrod@nrgoncology.org.
  • Pugh S; NRG Oncology Statistics and Data Management Center, 1600 JFK Blvd, Suite 1020, Philadelphia, PA 1903, USA. Electronic address: pughs@nrgoncology.org.
  • Paskett ED; The Ohio State University, 1590 N High Street, Suite 525, Columbus, OH 43210, USA. Electronic address: electra.paskett@osumc.edu.
  • Ford L; National Cancer Institute, Division of Cancer Prevention, 9609 Medical Center Drive, Rockville, MD 20892-9785, USA. Electronic address: fordl@mail.nih.gov.
  • McCaskill-Stevens W; National Cancer Institute, Division of Cancer Prevention, 9609 Medical Center Drive, Rockville, MD 20892-9785, USA. Electronic address: wm57h@nih.gov.
Gynecol Oncol ; 160(2): 625-632, 2021 02.
Article in En | MEDLINE | ID: mdl-33158510
ABSTRACT
Practice changing standardization of lower extremity lymphedema quantitative measurements with integrated patient reported outcomes will likely refine and redefine the optimal risk-reduction strategies to diminish the devastating limb-related dysfunction and morbidity associated with treatment of gynecologic cancers. The National Cancer Institute (NCI), Division of Cancer Prevention brought together a diverse group of cancer treatment, therapy and patient reported outcomes experts to discuss the current state-of-the-science in lymphedema evaluation with the potential goal of incorporating new strategies for optimal evaluation of lymphedema in future developing gynecologic clinical trials.
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Anthropometry / Lower Extremity / Patient Reported Outcome Measures / Genital Neoplasms, Female / Lymphedema Type of study: Etiology_studies / Risk_factors_studies Aspects: Patient_preference Limits: Female / Humans Language: En Journal: Gynecol Oncol Year: 2021 Document type: Article
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Anthropometry / Lower Extremity / Patient Reported Outcome Measures / Genital Neoplasms, Female / Lymphedema Type of study: Etiology_studies / Risk_factors_studies Aspects: Patient_preference Limits: Female / Humans Language: En Journal: Gynecol Oncol Year: 2021 Document type: Article